MEDCAC Review Of Anti-VEGF Drugs Rescheduled To March 21, 2012
This article was originally published in The Pink Sheet Daily
Executive Summary
Panel will consider benefits of Avastin, Lucentis in diabetic macular edema, addressing questions released by CMS.